{"organizations": [], "uuid": "3a65f6758400a740b68733fb6394c9d68490913b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180405.html", "section_title": "Archive News &amp; Video for Thursday, 05 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-applied-dna-signs-agreements-with/brief-applied-dna-signs-agreements-with-colorcon-for-molecular-tagging-in-pharmaceutical-nutraceutical-markets-idUSASC09UZN", "country": "US", "domain_rank": 408, "title": "BRIEF-Applied DNA Signs Agreements With Colorcon For Molecular Tagging In Pharmaceutical, Nutraceutical Markets", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-04-05T17:07:00.000+03:00", "replies_count": 0, "uuid": "3a65f6758400a740b68733fb6394c9d68490913b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-applied-dna-signs-agreements-with/brief-applied-dna-signs-agreements-with-colorcon-for-molecular-tagging-in-pharmaceutical-nutraceutical-markets-idUSASC09UZN", "ord_in_thread": 0, "title": "BRIEF-Applied DNA Signs Agreements With Colorcon For Molecular Tagging In Pharmaceutical, Nutraceutical Markets", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "dna sciences inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 5 (Reuters) - Applied DNA Sciences Inc:\n* APPLIED DNA SIGNS DEFINITIVE AGREEMENTS WITH COLORCON FOR MOLECULAR TAGGING IN THE PHARMACEUTICAL AND NUTRACEUTICAL MARKETS\n* AGREEMENTS INCLUDES MILESTONE PAYMENTS. LONG-TERM LICENSING ROYALTIES TO BE PAID TO APPLIED DNA FOLLOWING SALES.\n* ‍FIRST OF TWO MILESTONE PAYMENTS IS PAYABLE TO APPLIED DNA WITH SIGNING OF AGREEMENTS​\n* ‍TO GET SECOND MILESTONE PAYMENT ON INITIAL APPROVAL BY REGULATORY AUTHORITY FOR APPLICATION IN SOD PHARMACEUTICAL OR NUTRACEUTICAL PRODUCT APPLICATION\n* WILL SUPPLY TAGGANT AND AUTHENTICATION MATERIALS TO COLORCON IN EXCHANGE FOR LONG-TERM ROYALTIES\n* AGREEMENTS GENERALLY EXPIRE ON LATER OF OCTOBER 1, 2032 OR LAST EXPIRATION DATE OF ANY PATENT LICENSED UNDER AGREEMENT​ Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-05T17:07:00.000+03:00", "crawled": "2018-04-06T21:54:57.041+03:00", "highlightTitle": ""}